Site Best Viewed in 1024 x 768 Resolution
________________________________________________________________________________________________________________

 

News :

 

* Transasia Bio-Medicals Ltd. is proud to install its first state-of-the-art Coagulation analyzer – the Sysmex CS2000i at CMC, Vellore

* Transasia Bio-Medicals Ltd. is proud to install its first state of the art Haematology analyzer – the Sysmex XE AlphaN at Medicity, Gurgaon
* AIMA - Dr.J.S.Juneja Award for Creativity & Innovation – 2009
* Sysmex Transasia International Sceitific Seminar
* Sysmex Asia Pacific International Scientific Seminar
* APCON 2009
* Transasia Bio-Medicals Ltd., India’s Largest Clinical Diagnostic Co.  acquires a leading European
diagnostic company.
* Transasia participates at Clinical Lab Expo @ Chicago, USA
* Transasia Scientific Seminars – Empower yourself !
* ICRA assigns Highest rating  to the Bank lines of Transasia Bio-Medicals Limited
* Transasia crosses 2K Mark in Semi Automated Analyzers
* ISO ENCORE
* Arab Health EXPO
* ACBICON 2008
* 1st Transasia Scientific Seminar at Hyderabad
* Medica 2008
* Transasia participates at Clinical Lab Expo, USA
* Transasia continues its #1 position
*Awarded First State level Export award by Government of Maharashtra
*Transasia - at the forefront in APCON 2007, Chandigarh
*Transasia participated in the world’s biggest exhibition for Medical products “MEDICA’07” for the 10th consecutive year.
* Transasia Bio-Medicals signs an agreement with Grifols, Spain to exclusively distribute products in Transfusion Medicine for the Indian Market.
* "Transasia received HR Excellence Award"
* Another Milestone achieved with 1000th Machine Installation
* Transasia Bio-Medicals Ltd. bags an award for "Excellence in Exports"
from Amity International Business School in Feb, 2007
* TRANSASIA participates in GAPM Annual Conference
* Transasia receives the Award for the Most promising SME-Emerging India Awards (2005)
* Transasia bags "Niryat Shree"awards for two consecutive years

Transasia Bio-Medicals Ltd. installs its 100th fully automated, random access, Clinical Chemistry analyzer, the EM 200 at Shanti Clinic, Pune.

100 EM200 analyzers have been installed in a short span of just 11 months and Shanti clinic, Pune was felicitated as the esteemed 100th customer for this Biochemistry analyzer on 3rdApril 2010. This occasion was marked by a Pooja ceremony followed by a small get together at Shanti clinic to mark the installation of the EM200. Ms. Ratna Vaswani, Chairperson of the Vaswani mission graced the occasion with her presence. The Pooja ceremony was followed by a high tea for all the people present.

M

Transasia Bio-Medicals Ltd. is proud to install its first state of the art Haematology analyzer – the Sysmex XE AlphaN at Medicity, Gurgaon.

Medicity - the dream of Dr. Naresh Trehan, world renowned cardiothoracic and vascular surgeon is a multi-disciplinary, high-tech medical institute modeled after global centres of excellence. And Transasia analyzers find a place of pride in the high-tech laboratory of one of India's largest multi-specialty tertiary care hospitals. The Sysmex XE AlphaN brings total automation to the zenith with its integrated fully automated 5 part differential Haematology analyzer and automated slide preparation unit. Add to this, the power of networking by SNCS (Sysmex Network Communication Systems) to maintain total quality on Sysmex Haematology analyzers and you have total Haematology analysis in a “walk away” environment.Valued Relationship Catering To The Patients Need.

M

Transasia Bio-Medicals Ltd. is proud to install its first state-of-the-art Coagulation analyzer – the Sysmex CS2000i at CMC, Vellore.

Christian Medical College, Vellore has one of the best and most well equipped Transfusion Medicine and Immunohaematology departments in the country which deals with about 2000 blood samples for cell counts and over 400 samples for Hemostasis screening per day. And the Sysmex CS 2000i analyzer finds a place of pride in one of the world’s premier institutes and a pioneer in the field of Hemostasis.

The Sysmex CS 2000 – i is a State of the Art, Fully Automated Coagulation Analyzer with HIL Detection and Platelet Aggregation Assays.

M

AIMA - Dr.J.S.Juneja Award for Creativity & Innovation – 2010

In its official citation for the award, AIMA has mentioned that :
“Transasia Bio-Medicals Ltd. is a leader in clinical diagnostic segment of healthcare industry. Transasia Bio-MedicalsLtd. has achieved this distinction by pursuing the pathof creativity and continuous innovation, which has led it to unstinted growth and profitability. The company has filed a number of Indian and overseas patent applications which is a testimony to its research base.
Transasia Bio-medicals Ltd.'s strength has been customer focus backed by strong manufacturing facilities and indigenous R&D. The company has presence in over 65 countries including developed ones like Italy, Germany, France, USA andAustralia.

All India Management Association recognises Transasia Bio-Medicals Ltd., Mumbai, a highly innovative, creative and quality conscious enterprise and bestows the prestigious AIMA – Dr.J.S.Juneja award for Creativity and Innovation upon the company through its visionary and dynamic Chairman & Managing Director, Mr. Suresh Vazirani.”

All India Management Association (AIMA) is the National Apex body of Management Profession in India with over 31,000 members from all over India.

Through this award, AIMA recognises Transasia's 360 degrees approach to business from R&D & Manufacturing to Marketing & Service leading to a breakthrough in the field of healthcare thereby saving precious lives.

M

Sysmex Transasia International Scientific Seminar

Transasia & Sysmex have always propagated the cause of Science through regular CMEs & updates in the field ofHematology. The 7th Sysmex Transasia International Scientific Seminar was organised on the 6th of February 2010 at Hotel ITC Grand Central, Mumbai. The objective of this seminar was to demonstrate the clinical utility of new and existing analytical parameters in improving laboratory diagnosis of diseases. Dr. Rolf Hinzmann acquainted the delegates with more information in his talk: “Haematological parameters can detect iron deficiency in clinical conditions where the classical serum tests fail”. Dr.Steve Johnson shared a study that his laboratory undertook to evaluate a semi-qualitative parameter, NEUT-X, on the Sysmex XE-2100 haematology analyser to detect myelodysplasia in his talk: “Neut-X- A new tool”. About 200 doctors from all over India participated in this intellectual seminar.

M

APCON 2009

The Annual conference of the Indian association of Pathologists and Microbiologists – APCON 2009 was held at Science City, Kolkata in association with the Calcutta Association of Practising Pathologists.

Transasia Bio-Medicals Ltd. was the principal sponsor of the event where a number of distinguished speakers, who are pioneers in their respective fields were invited.

Transasia sponsored the Banquet on 19th December 2009 at the majestic Fort William where famous singer Usha Uthup enthralled the crowd with her mind blowing performance.Transasia also supported many other activities at APCON 2009.

M

Sysmex Asia Pacific 2nd International Scientific Seminar

The Sysmex Asia Pacific 2nd International Scientific Seminar was organised at Ho Chi Minh City, Vietnam on the 14th & 15th of December 2009. About 46 of India's top pathologists attended this seminar at Vietnam. The Indian contingent was the second largest group amongst the 350 doctors from across Asia Pacific. Speakers from across four continents were invited to speak on clinical utility of novel parameters and approaches in diagnosing diseases as well as looking into the power of technology in cell analysis.



M







Transasia Bio-Medicals Ltd.,India’s Largest Clinical Diagnostic Co.  acquires a leading European diagnostic company.

| Lachema Media Coverage |
| Lachema Factory |

TRANSASIA BIO-MEDICALS LTD., India’s largest clinical diagnostic company has acquired Pliva Lachema Diagnostika, a 42 year old company located in Czech Republic
 
PLIVA Lachema Diagnostika, is engaged in the development, production and marketing of In Vitro Diagnostics products consisting of a range for Urine analysis, Biochemistry and Microbiology. The company, with its extensive marketing and distribution network in the countries of Central and Eastern Europe adequately complements the current market potential and product lines of Transasia and Erba Mannheim. It has state-of-the-art Manufacturing and Research & Development facilities at Brno, employing over 100 people.

The acquisition by Transasia through its German subsidiary ERBA Diagnostics Mannheim GmbH, provides a great opportunity for Transasia and ERBA to usher in newer products in the dynamically developing markets of Asia. Also, Lachema’s customers in Central and Eastern Europe will have access to Transasia’s extensive product range in Clinical Chemistry, Immunoturbidimetry and Immunology. Transasia Bio-Medicals Ltd. and ERBA Diagnostics Mannheim plan to invest more than USD 1 Million in Lachema to increase its manufacturing capacities and add new products in the near future for meeting growing demand. This new acquisition greatly expands the spectrum of technologically advanced products and manufacturing capabilities of Transasia. Transasia and ERBA customers will now benefit with these products being offered at high quality and affordable prices.

This acquisition now allows Transasia customers access to a wide range of solutions for microbiology and usher in a quicker and better diagnosis for a range of health issues, which is great news for the Indian healthcare scene.
This acquisition will augment the company’s vision of bringing benefits of the best diagnostic technologies  within reach for its vast populations in developing countries. The company is a partner of the Clinton foundations Aids control Program in Africa and India.

M

Transasia participates at Clinical Lab Expo @ Chicago, USA


Transasia Bio-Medicals Ltd. participated at the Annual Meeting and Clinical Lab Exposition, organized by American Association for Clinical Chemistry from July 19-23, 2009 at Chicago,USA.


This years clinical expo showcased new science and technology in all areas of clinical  diagnostics, automation, information systems, point-of-care, OEM and Biotech.


Dynamic educational sessions and information on the latest products and services available for clinical scientists were the highlight of AACC 2009.


Mr.Suresh Vazirani represented India at the International Market Briefing session where he spoke on the Indian IVD market and Asian Off-shore Manufacturing by implementing the use of free trade zones. His talk was well appreciated by all the delegates present.


Transasia’s stall also received overwhelming response at the exhibition.






M

Indian Flag outside Chicago O’hare airport …. The Indian Tricolor stands tall  in the USA…


Mr.Suresh Vazirani, CMD Transasia .. making the presentation on the IVD Market in India … the presentation was well appreciated by all those present.


The Erba Mannheim booth in AACC’09 .. showcased products like XL-300, XL-640, Chem-7 , Chem-5 v3 , ErbaLyte and others..

Transasia Scientific Seminars – Empower yourself!

Transasia Bio-Medicals Ltd. is conducting Scientific Seminars at various cities across India for the benefit of its esteemed customers. These events not only give a chance for all the invitees to understand the complexities involved in clinical interpretations of various pathological testings but also a common forum to share there ideas and personal experiences.

TSS Coimbatore
The Residency, Coimbatore in Tamil Nadu was the venue for the 2nd Transasia Scientific Seminar on 6th June 2009, where more than 100 eminent doctors participated in a symposium of informative lectures and discussions.

Dr.Sujay Prasad, Director, Anand Diagnostic Laboratory, Bengaluru explained to those present on the topic “Cell Counter Analysis of Immature Granulocytes”. He also explained the importance of “Managing Information in a Clinical Lab”

Mr.Sunil Dhadkar, Product Manager – Biochemistry Instruments, in his presentation on Fully Automated Analyzers in Clinical Chemistry,  emphasised on the features of EM200 – our fully automated, random access, clinical chemistry analyzer.

A presentation on the Role of Laboratory Assessment in Differential Diagnosis of Acute Coronary Syndrome was made by Mr. Sayantan Barat, Product Manager – Biochemistry Reagents, which was followed by the launch of Cardiac Markers – ErbaQik Troponin I and Cardiac Duo. He also stressed on the Importance of External Quality Assurance and EMQAS programme by Transasia Bio-Medicals Ltd.

TSS Patna
Hotel Chanakya @ Patna was the setting for the 3rd Transasia Scientific Seminar on the 20th of June 2009.
Dr. Renu Saxena, Professor and Head, Department of Haematology – All India Institute of Medical Sciences, gave a presentation on “Approach to Bleeding Disorders and Interpretation of Automated Cell Counter Parameters”

This educative seminar by Dr.Saxena was followed by presentation on EM200 AND Cardiac markers by Transasia product managers.

TSS Pune
Dr. Swati Pai from the Department of Lab Medicine, Manipal Hospital, Bengaluru was one of the guest speakers at the seminar conducted by Transasia at The Pride Hotel, Pune on the 25th of July 2009.
Dr.Pai explained to the delegates about various aspects of “Laboratory Diagnosis of Thrombophilia” and the appropriate tests to be performed to envisage a clinical presentation.

The second guest speaker of the day was Dr. Parag Dharap of Dr.Dharap’s Diagnostic centre, Mumbai. In his talk on “Quest for Automation”, Dr.Dharap highlighted the prerequisites that every lab must follow for selection of  Fully Automated Instrumentation in Biochemistry.

M

 

ICRA assigns Highest rating  to the Bank lines of Transasia Bio-Medicals Limited

ICRA has assigned A1+ (pronounced A one plus) indicating the highest credit quality to short term debt instruments and LAA- (pronounced as L double A minus) indicating high credit quality to long term debt instruments rating to the Rs. 200 million fund based and non-fund based limits of Transasia Bio-Medicals Limited (Transasia). 

 The assigned ratings take into account Transasia’s leadership position in the domestic IVD (In-Vitro diagnostics) market with strong promoter background and management expertise. Transasia has pan India marketing and distribution network with strong focus on after sales service which is a source of competitive advantage. The company has exclusive tie-ups with international players like Sysmex, Diesse, Medica for advance IVD equipment and cater to all segments comprising of private hospitals and labs, public hospitals and Government owned entities. The financial risk profile of the company is very strong with relatively higher profitability and return on capital employed. The company is debt free and has strong liquidity in the form of investments generated out of past profits.

About the company :

Transasia Bio-Medicals Limited (‘Transasia’ or ‘the Company’) was founded by Mr Suresh Vazirani in 1985. Today, the Company is recognized as a largest player in the Diagnostic world. It has the largest Sales and Installation base with over 15,000 installations all over the country. In collaboration with leading International companies like Sysmex, Medica, Grifols, Diesse, Fujirebio and others it offers an extensive range of products in the In-Vitro Diagnostics (‘IVD’) space. Transasia is the only Indian Manufacturing & Exporting Company for sophisticated Biochemistry Analyzers. The Company sells its produce in domestic market as well as exports to 55 countries. The Company manufactures entire range of Clinical Chemistry Analysers, Elisa Readers and Microplates, Readers. Manufacturing is undertaken at 3 units, at Daman, SEEPZ and Baddi. All units are ISO 9001:2000 & ISO 13485: 2003 certified. The Company is head quartered in Mumbai and has offices across India with a team of 102 service engineers & over 250 sales engineers.

M

Transasia Bio-Medicals Ltd. has reached the milestone of production of 2000 semi automated analyzers in this year.
Erba Chem 7, Chem5plus v2 & Chem 5X are clinical chemistry systems with extensive Biochemistry test menu and elaborate QC programmes. Add to this, the user friendly software and these semi automated analyzers are a boon for any laboratory looking to ease their workloads.



Team Transasia is geared up in the last quarter of the financial year to beat its own record in the production of these analyzers.

ISO ENCORE

TBM’s  “ Warehousing and distribution operations of Finished Goods “ at Pondichery and Daman –1 have been ISO 9001 and ISO 13485 certified by UL India.

This is in addition to the ISO certification obtained by Transasia in January 2008 for its manufacturing facilities across various locations.

M


ARAB HEALTH EXPO
( 26th – 29th January 2009)


Transasia Bio-Medicals Ltd. and its German subsidiary Erba Diagnostics Mannheim GmBH participated at the Arab Health Expo from 26th – 29th January 2009 at Dubai Internation Exhibition Centre, Dubai, United Arab Emirates.

Our booth at the Middle East's biggest gathering of medical professionals showcased our product range and also our new product lines.

ACBICON 2008 (Dec 19th – 21st 2008 ) :
35th National Conference of Association of Clinical Biochemists of India coincided with the Platinum Jubilee celebration of the hosting Institute Ramakrishna Mission Seva Pratishthan, Vivekananda Institute of Medical Sciences.

The Event was very well attended by Over 1000 delegates. Transasia Bio-Medicals Ltd. was one of the co-sponsors of the event where a number of distinguished speakers, who are pioneers in their respective fields were invited. The Conference, also showcased the ‘state-of-the-art’ equipment & products of several companies at the exhibition.

Besides dinner parties, several social-cum-cultural programmes were organised. Transasia sponsored the Banquet on 20th Dec. Famous singer Usha Uthup who performed at the Banquet specially thanked Transasia. Mr. Suresh Vazirani also presented the Memento to her.

M





Transasia conducted the 1st Transasia Scientific Seminar at Hyderabad on 15th Nov’08.

Dr V P Antia, Head of Haematological Medicine, Breach Candy Hospital Trust, Mumbai & Consultant Haematologist – Tata Memorial Hospital & Jaslok Hospital, Mumbai, shared his expertise on “Approach to Anaemia using Modern Technology”.

Ms Sudha Srinivasan, Sr. Product Executive, Transasia, gave a presentation on the topic “Dengue – The Menace”.

There was also a demonstration of Transasia products for the benefit of the participants.
Around 100 delegates attended the informative sessions.

Transasia intends having these seminars alongwith product demos at various cities across India for the benefit of its esteemed customers.

 

M





November 2008 was witness to what is probably the world’s biggest health care industry exposition…. Medica 2008.

From November 19 - 22, 2008, the fairgrounds in Düsseldorf, Germany hosted MEDICA, 40th International Trade Fair with Congress.This year Medica also hosted the 40th World Forum for Medicine.

The World's Largest Forum for In-Patient and Out-Patient Medicine was the center of attraction for all those involved in the health service. As the leading international trade fair for the medical industry, MEDICA 2008 featured about 4,300 exhibitors, two major congresses, an ancillary program and numerous special events.

Just like every year, Transasia Bio-Medicals Ltd. and its German subsidiary Erba Diagnostics Mannheim GmBH had a major presence.  Our booth showcased our product range and also our new product lines.

M

Transasia participates at Clinical Lab Expo, USA

Transasia Bio-Medicals Ltd. participated at the the Largest Clinical Lab Exposition in the World, , organized by American Association for Clinical Chemistry from July 29-31'08 at Washington, DC,USA.

This years clinical expo saw a record number of exhibiting companies with more booth space than in previous years. Transasia stall received overwhelming response at the exhibition.

M

India's In-Vitro Diagnostics Market Double Digit Annual Growth Drove Stronger Adoption of Automation With Over 1,800 Automated Systems Detected in 2007

Clearstate's IVD Gateway Database in India provides insights on instrument installation and test consumption trends by tracking market changes and usage patterns quarterly.

Singapore (PRWEB) May 7, 2008 -- Following the successful launch of its South East Asia (SEA) usage database for In-vitro Diagnostics (IVD) in 2006, Clearstate has expanded its IVD Gateway Database coverage to one of the largest and most challenging market in the region, India.

India's large geography and non-homogeneous usage environment demand a large sampling of hospital and stand-alone laboratories to ensure a robust and well-represented analysis of the IVD market. The Gateway database screened over 5,000 labs and surveyed in detail over 800 of the highest test volume facilities in India. Clearstate also took an additional measure to increase the thoroughness of the survey input and sizing estimates through validation with major distributors and suppliers.

Similar to the SEA database, the India database details unit installation of diagnostics analyzers, the volume consumption of reagents and tests assays, and the penetration of key IVD brands by city, model and user segment.

However, according to Ms. Ivy Teh, Clearstate's Managing Director, "We have further improved our database offering by providing value-added interpretations of market insights and share analysis. Instead of just presenting data, we now provide analysis on test breakdown run on automated vs. semi-automated systems, we have average installation age of over 10 leading brands and models and where they are located to help clients determine where and when replacements are coming up."

Ms. Teh added that the improved database showed more technology adoptions and higher end automated equipment purchases in large lab facilities especially in the South and West regions of India. For instance, automated systems in Clinical Chemistry have grown to close to 1,800 units across India, that represents only 12 - 15% of total analyzers installed but nearly 50% of the total revenue, valued at approximately USD 35 - 40 million in 2007. Trends observed in the database also revealed that local players are gaining stronger market presence, with Transasia extending its market leadership over international players specifically in Clinical Chemistry and Hematology.

Other interesting insights extracted from India's IVD Gateway include:

- Determine brand share and placements: Transasia's Erba Chem Series and Bayer's small RA Systems are the most placed Clinical Chemistry (CC) analyzers in all types of facilities. These analyzers act as back-up instruments in larger lab facilities. Bayer is pushing more of it Advia Systems that has seen a jump in installations in recent years while phasing out the old RA systems.

- Assess opportunity by geography: South and West India have the highest demand for IVD tests relative to other regions in the country, representing over 60% of total IVD tests. The majority of tests are still centered around key urban cities, primarily Mumbai, Delhi, Chennai, Bangalore and Kolkata.


M




 

Awarded First State level Export award by Government of Maharashtra

Transasia which is the first Indian company to manufacture & export sophisticated state of the art Blood analyzers and Reagents has been awarded the First State level Export award & the Second Regional award by The Industries Department, Govt. of Maharashtra in recognition of the export performance for the year 2006- 07 and 2005-06 respectively.

The award was presented to Mr Suresh Vazirani, CMD, Transasia Bio- Medicals Ltd by Shri Subodh Kant Sahai, Hon'ble Minister of State (Independent Charge), Ministry of Food Processing Industries, Govt. of India on 25th April'08 at a function held in Mumbai.

Transasia is playing a stellar role in bringing world-class products within reach of laboratories across the
globe. Today, Transasia's products enjoy a strong global presence and are exported to Italy, Germany, France, Australia, China, Turkey, USA., Latin America, Africa, Russia, Middle East,SAARCand Asia.



M


"Transasia Bio-Medicals Ltd awarded ISO 13485"

Transasia Bio-Medicals Ltd, leader in the Clinical Diagnostics Segment across the Indian healthcare sector, which aids in diagnosing life threatening diseases faced by the humankind such as, AIDS, Tuberculosis, Cancer and Diabetes etc. has been awarded ISO 13485 (Quality Management Systems for Medical Devices) by UL India, a certifying body to foster quality assurance and improvement.

UL India is an affiliate of Underwriters Laboratories Inc., USA., which is one of the world's largest Conformity Assessment Service Provider.

Transasia Bio-Medicals Ltd is one of the few Indian companies which has been awarded the ISO 13485. The certification has reinforced the vision of the company to provide quality medical diagnostic products & services at Affordable prices, through Cost and Quality conscious systems of Materials and Process Control.

Transasia has always recognized Quality & R&D as the prime drivers of innovation and leadership and strives to be among the top ten diagnostic players in the world. Transasia's young and enthusiastic team of experts in software, mechanical engineering, electronics and embedded software and Bio-chemistry has built an impressive track record of successful projects. The Research and Development department, a team of 90 research and development engineers, constantly work to bring out products with appropriate technology and features to meet the changing customer needs.

The total Indian healthcare sector is valued at US$ 34 billion and is projected to grow to nearly US$ 40 billion by 2012. The diagnostic and pathology market is around 2% of the overall healthcare market. The diagnostic market has been growing at 15-20% and by all indications shall continue to grow for another 10 years at this rate. One of the major drivers has been the basic demographic change in India, the migration to urban cities and more & more people having access to modern healthcare. Impetus has also been provided by the increasing investments in hospitals, clinical laboratories and automated chemistry labs.

The world faces many challenges in the form of serious diseases and Transasia's journey continues to provide much of the technology to diagnose the diseases earlier and save precious lives and reinforce the adage "Prevention is definitely better than cure".

M



 

 

 

Transasia - at the forefront in APCON 2007, Chandigarh

TRANSASIA made its presence in the 56th Annual Conference of the Indian Association of Pathologist and Microbiologist (APCON) which was held at Chandigarh from the 26th to the 29th of November 2007 by being the main sponsor for the event. The participation was made in the form of an exclusive and extraordinary stall at the venue, with our automated products on display.

The three days of the conference were flooded with delegates who came from all across the country. Among the list of amenities that was provided during the three day conference to the delegates, TRANSASIA provided transportation for the delegates and also provided with Delegate bags to each person at the conference. In addition, TRANSASIA also sponsored scientific sessions and lectures by Foreign Speakers. The Registration counter was also sponsored by TRANSASIA.

As a grand finale to the splendid participation, Transasia left its profound impact on more than 850 delegates by organizing a unique BANQUET with a variety of cuisines at the Rock Garden, Chandigarh. Folk dances and enthralling music provided by a hi-tech DJ regaled the delegates till late night. There was a sparkling fire-cracker show especially for the entertainment of the guests.

To add to the excitement and fun, there was an open quiz for the delegates which was held during the day. There was a lucky draw for the participants. Dr. Subhir Dutta-Former Presdient APCON, Dr. J.S. Dalal-Director of Research & Medical Education- Punjab, Dr. R.K. Vasistha-Organising Secretary of APCON 2007 and Mr. Suresh Vazirani-Chairman & Managing Director-Transasia felicitated the winners with exciting prizes like I-Pods and cell phones.

With the strong team effort of the Transasia Employees, the event proved to be a good platform to showcase our products - which are not only advanced in technology but also very popular with our customers. The products at display received overwhelming response and appreciation.

Our heartfelt thanks to Dr. Vasistha, Dr. Kusum Joshi, Dr. Neelam Verma- PGI, Chandigarh and Dr. Harsh Mohan-Medical College, Chandigarh for their support in making APCON a grand success.

With an increasing bunch of events to participate in, more awards being added to the company's kitty every year, Transasia- The No. 1 Diagnostic Company in India strives to achieve its dream of being the No. 1 Diagnostic Company in the world

M


Transasia participated in the world’s biggest exhibition for Medical products “MEDICA’07” for the 10th consecutive year.
It was a momentous occasion for Transasia, as it participated in the world’s biggest exhibition for Medical products “MEDICA’07” for the 10th consecutive year.

From a humble beginning in 1995 with just a handful of products, the display in 2007 included the XL-640 & XL-200 Automated Clinical Chemistry systems, Chem-5 v3 & Chem-7 Semi-automated systems, Clinical Chemistry Reagents and a complete line of Urine Analyzers.

A strong team of 12 people represented Transasia/ Erba Mannheim at the Medica’07 exhibition under the banner of Erba Diagnostics Mannheim GmbH; Transasia’s 100% fully owned subsidiary.

The products on display at Medica’07 received overwhelming response and appreciation from the international trade community and Transasia business partners. With more exciting collaborations and product launches in the coming months and the legacy of accolades, recognition and awards; TRANSASIA is marching ahead to becoming part of the world’s leading diagnostic companies, together with it’s wholly owned subsidiary ERBA MANNHEIM DIAGNOSTICS GmbH, Germany.

 


 

 

M

Transasia Bio-Medicals signs an agreement with Grifols, Spain to exclusively distribute products in Transfusion Medicine for the Indian Market
The new line of products that Transasia would distribute would be WaDiana Compact®, DG Spin™, DG Therm™ in the instruments section, DG Gel® cards and Grifols Red Blood Cells in the reagents section.

M

* "Transasia received HR Excellence Award" It is yet another proud moment for Transasia especially our HR Department as we have been conferred with the "HR Excellence Award" at a recently concluded Global HR Summit at Amity International Business School, Noida. The award was felicitated to us on the 23rd August’2007.

The award has been bestowed to Transasia Bio-Medicals Ltd. by Amity International Business School, based on their annual comprehensive
research on HR practices

 

M

Another Milestone achieved with 1000thMachine Installation
Transasia Bio-Medicals has crossed one more mile stone with the 1000th Installations of XL series range of Automated Analyzer.

 

 

M

Transasia Bio-Medicals Ltd. bags
an award for "Excellence in Exports" from Amity International Business School in Feb, 2007

Transasia Bio-Medicals Ltd. has been conferred with yet another award, this time for "Excellence in Exports." given by Amity International Business School during their International Business Summit that was organized in February 2007. The award is the result of a six-month in-depth research on the analysis of exports in different sectors in an attempt to identify the companies that have contributed significantly in promoting exports from India.

M

TRANSASIA participates in GAPM Annual Conference
Transasia participated at the GAPM Annual Conference(Gujarat Association of Pathology & Microbiologists) held on 3rd & 4th Feb'07 at NDDB Campus, Karamsad, Anand, Gujarat. The event was attended by more than 200 pathologists from all over Gujarat.

M

Transasia receives the Award for the Most promising SME-Emerging India Awards(2005)
It was a proud moment for Transasia to be the recipient of the emerging India award for the most promising SME in 2005. The award is a recognition for the steady progress and growth that Transasia has been achieving since its inception.

 

M

Transasia bags "Niryat Shree"awards for two consecutive years:
Transasia received the coveted FIEO( Federation of Indian Export Organizations) set-up by Ministry of Commerce, Govt. of India) Awards for 2 consecutive years. The award is a recognition for excellence in Exports for the year 2003-04 and 2004-05. Mr. Suresh Vazirani and Mrs. `Mala. Vazirani received the award from the Honourable Union Minister of Commerce and Industry, Shri Kamal Nath. This is the third such NATIONAL EXPORT AWARD won by TRANSASIA .

 

 

M